Alcoholism is a persistent substance abuse disorder that is associated with negative health, social, and economic outcomes. Treatment strategies for alcohol use disorders are limited, and only three drugs have been approved by the FDA for treatment. Although behavioral therapy and drug combination strategies improve abstinence outcomes, the majority of those in treatment will not achieve long-term abstinence. Therefore, better treatment strategies are needed. While much progress has been made toward understanding the neurobiology of alcoholism, this knowledge has not been effectively translated into treatment strategies. Animal models of alcohol drinking have been crucial to this research effort, but until recently there have been few procedures that effectively model alcoholism by producing binge-like drinking, withdrawal, and relapse behavior. In the last five years the intermittent alcohol access (IAA) model, which uses repeated cycles of scheduled alcohol deprivation and reinstatement to elevate drinking, has been established as such a procedure, with substantial evidence that escalation of drinking produced by IAA is mediated by similar mechanisms as in human alcoholics, which include transcriptional regulation that alters functioning of mesolimbocortical reward pathways. The IAA model. The studies reported herein characterize changes in gene expression in mesolimbocortical brain regions associated with development of maladaptive binge-like alcohol drinking due to scheduled abstinence, particularly in the nucleus accumbens, which regulates motivated behavior. Furthermore the IAA model is characterized with regard to effectiveness in 2 ethanol-preferring C57BL/6 inbred mouse strains, and the influence of concurrent access to multiple alcohol concentrations is examined. Finally, the potential of naltrexone and novel mu-opioid receptor-selective antagonist NAQ to modulate alcohol drinking under continuous access and intermittent access procedures is reported. Microarray analysis is used to analyze the transcriptome in prefrontal cortex, nucleus accumbens, and ventral midbrain of C57BL/6NCrl mice after alcohol deprivation, and to identify differentially expressed genes and gene co-expression networks in C57BL/6J mice during continuous access, as well as after six cycles of IAA. Differentially expressed genes, network hub genes, and regulation mechanisms represent high priority targets for further study in binge-like drinking behavior, with the goal of translating this knowledge to treatment strategies for alcoholism.

O MCH é um neuropeptídeo sintetizado preferencialmente no hipotálamo que exibe projeções para todo o neuroeixo, podendo modular vários processos fisiológicos, como a ingestão aguda de alimento. Um alvo de suas projeções é o núcleo accumbens (Acb), componente do estriado ventral envolvido na recompensa de estímulos hedônicos. Nossa contribuição visa mapear as células imunorreativas (ir) ao MCH responsáveis pelas aferências do Acb, onde também investigamos aposições entre os sistemas MCH, GABA e ChAT. Utilizaram-se os métodos de simples e duplas imunoperoxidases e combinação de imunofluorescência e captação de traçadores retrógrados. A maior densidade de fibras ir-MCH ocupa a parte shell do Acb (AcbSh); as aferências ir-MCH partem, por exemplo, da área hipotalâmica lateral e área perifornicial. Controles anterógrados foram obtidos a partir da LHA. Observaram-se aposições entre terminais ir-MCH e células ir-GABA e ir-ChAT, no AcbSh. Assim, sugere-se que os territórios hipotalâmicos que contém MCH inervem o AcbSh e contatem outros sistemas neuroquímicos no Acb. / MCH is a neuropeptide synthesized preferentially in the hypothalamus that shows projections throughout neuraxis, and may modulate various physiological processes such as food intake. One target of its projections is the nucleus accumbens (Acb), a component of the striatum involved in reward of hedonic stimuli. Our contribution aims to map immunoreactive (ir) cells responsible for the MCH inputs of the Acb, and to investigate appositions between MCH fibers, GABA and ChAT cells. We used the single and double immunoperoxidase methods and immunofluorescence combined with retrograde tracer. The highest density of fiber MCH-ir occupies the shell part of the Acb (AcbSh); MCH-ir inputs are mainly from lateral hypothalamic and perifornical areas. Anterograde controls were obtained from the LHA. We have founded appositions between MCH-ir terminals and GABA- and ChAT-ir cells at AcbSh. Thus, is suggested that hypothalamic areas containing MCH innervate the AcbSh and contact other neurochemical systems systems in the Acb.

O núcleo acumbens (Acb) é subdividido em core e shell (AcbSh). Há evidências que as divisões do Acb vão além da dicotomia core-shell e que regiões pobres em tirosina hidroxilase (TH) e calretinina (Calr) formam um sistema de corredores no AcbSh. Para detalhar melhor a organização do Acb investigamos a distribuição de TH, Calr, DARPP-32 e do transportador de dopamina (DAT). Em seguida, foi comparada a distribuição destes marcadores com a das subunidades GluA2/3 dos receptores de glutamato do tipo AMPA. Finalmente, exploramos se as aferências pré-frontais são direcionadas à distintos compartimentos do AcbSh. Nossos resultados revelaram que regiões que contém neurônios GluA2/3+ intensamente marcados formam um sistema de corredores no AbSh que coincide com áreas pobres em TH, Calr e DAT. Os experimentos de rastreamento anterógrado indicaram que somente uma pequena parte das aferências pré-frontais é direcionada aos corredores. Nossos resultados delinearam um sistema de corredores no AcbSh que provavelmente constitui um compartimento neuroquímico altamente especializado. / The nucleus accumbens (Acb) is subdivided in core and shell (AcbSh). There is evidence that accumbal subdivisions go beyond this core-shell dichotomy and that regions poor in tyrosine hydroxylase (TH) and calretinin (Calr) form a corridor system in the Acbsh. To better detail accumbal organization, we investigated the distribution of TH, Calr, DARPP-32 and of the dopamine transporter (DAT). Then we compared the distribution of these markers with that of the AMPA-type glutamate receptor subunits GluA2/3. Finally, we explored whether prefrontal afferents are directed to distinct AcbSh compartments. Our findings revealed that regions containing intensely labeled GluA2/3+ neurons form a corridor system in the AcbSh that coincides with regions poor in TH, Calr, and DAT. Anterograde tracing experiments indicated that only a small portion of the prefrontal afferents is specifically related to the corridors. Our findings delineated a complex corridor system in the AcbSh which might constitute a highly specialized neurochemical compartment.

In the last decade, (non)prescription opioid abuse, opioid use disorder (OUD) diagnoses, and opioid-related overdoses have risen and represent a significant public health concern. One method of understanding OUD is as a disorder of choice that requires choosing opioid rewards at the expense of other nondrug rewards. The characterization of OUD as a disorder of choice is important as it implicates decision- making processes as therapeutic targets, such as the valuation of opioid rewards. However, reward-value measurement and interpretation are traditionally different in substance abuse research compared to related fields such as economics, animal behavior, and neuroeconomics and may be less effective for understanding how opioid rewards are valued. The present research therefore used choice procedures in line with behavioral/neuroeconomic studies to determine if drug-associated decision making could be predicted from economic choice theories. In Experiment 1, rats completed an isomorphic food-food probabilistic choice task with dynamic, unpredictable changes in reward probability that required constant updating of reward values. After initial training, the reward magnitude of one choice subsequently increased from one to two to three pellets. Additionally, rats were split between the Signaled and Unsignaled groups to understand how cues modulate reward value. After each choice, the Unsignaled group received distinct choice-dependent cues that were uninformative of the choice outcome. The Signaled group also received uninformative cues on one option, but the alternative choice produced reward-predictive cues that informed the trial outcome as a win or loss. Choice data were analyzed at a molar level using matching equations and molecular level using reinforcement learning (RL) models to determine how probability, reward magnitude, and reward-associated cues affected choice. Experiment 2 used an allomorphic drug versus food procedure where the food reward for one option was replaced by a self-administered remifentanil (REMI) infusion at doses of 1, 3 and 10 μg/kg. Finally, Experiment 3 assessed the potential for both REMI and food reward value to be commonly scaled within the brain by examining changes in nucleus accumbens (NAc) Oxygen (O2) dynamics. Results showed that increasing reward probability, magnitude, and the presence of reward-associated cues all independently increased the propensity of choosing the associated choice alternative, including REMI drug choices. Additionally, both molar matching and molecular RL models successfully parameterized rats’ decision dynamics. O2 dynamics were generally commensurate with the idea of a common value signal for REMI and food with changes in O2 signaling scaling with the reward magnitude of REMI rewards. Finally, RL model-derived reward prediction errors significantly correlated with peak O2 activity for reward delivery, suggesting a possible neurological mechanism of value updating. Results are discussed in terms of their implications for current conceptualizations of substance use disorders including a potential need to change the discourse surrounding how substance use disorders are modeled experimentally. Overall, the present research provides evidence that a choice model of substance use disorders may be a viable alternative to the disease model and could facilitate future treatment options centered around economic principles.

Drug-specific reward and associated effects on neural signaling are often studied between subjects, where one group self-administers drug and a separate group self-administers a natural reinforcer. However, exposure to drugs of abuse can cause long-term neural adaptations that can affect how an organism responds to drug reward, natural reward, and their reward-associated stimuli. Thus, to isolate drug-specific effects it is important to use models that expose the same organism to all of the aforementioned. Multiple schedules provide a means of dissociating the rewarding effects of a drug from the rewarding effects of food within a single animal. Further, drug users do not take drugs in isolation; rather, they are often faced with several concurrently available commodities (e.g. monetary goods, social relationships). Thus, using choice measures to assess the relative subjective value of drug reinforcers in both humans and animals promotes a translational understanding of mechanisms that govern drug-associated decision-making. Thus, in order to gain a more translational view of the neurobehavioral mechanisms that underlie drug-associated behavior, in the first study, glutamate was measured in the nucleus accumbens core (NAcC) and prefrontal cortex (PrL) in freely-moving rats as they behaved in a cocaine-food multiple schedule procedure. In the second study, oxygen dynamics were measured in the orbitofrontal cortex (OFC) of freely-moving rats as they behaved in a cocaine/food choice procedure. The results from the first study showed that, in the NAc and PrL, there was an increase in glutamate release when animals earned cocaine. Further, the number of glutamate peaks that occurred per cocaine lever press and per cocaine reinforcer was increased compared to food. In the second study, OFC oxygen dynamics were positively correlated with cocaine/food choice and generally tracked preference. Further, OFC oxygen dynamics were greater to cocaine related events. Taken together, these results showed the feasibility of combining electrochemical measurements with complex drug-related behavioral procedures. These results also highlight the importance of the PrL, NAcC, and OFC in the valuation of drug and non-drug commodities. Overall, these results add to our understanding of the neurobehavioral mechanisms that guide drug-associated behavior and create more precise experimental avenues to research potential treatments.

安非他命與古柯鹼皆屬心理興奮性藥物(psychostimulants)，在藥理上有很多功能相似的機制，而且兩種藥物濫用成癮的問題一直是臨床及基礎研究所關心的問題。就動物行為模式而言，安非他命與古柯鹼具有影響包括反射性及制約學習性的行為表現的效果。若針對藥物的酬賞性做探討時，制約性場地偏好行為模式的相關研究益發受到重視，本研究實驗一先針對此作業之操弄時間及環境變項做一探討，再研究安非他命與古柯鹼之作用機制。過去的研究發現，週邊注射安非他命或古柯鹼與某環境刺激配對能引發制約性引發場地偏好的傾向，但兩藥的行為現象卻對藥理的操弄呈不一致的結果，隱含兩藥背後的神經機制可能也不同。其中阿控博核是一個值得再驗證的區域。阿控博核被認為是動機系統與運動系統的介面。此部位因其解剖及生化功能的異質性，故實驗二針對其次分區進行中樞藥物注射，於是直接將安非他命(10，15μg)與古柯鹼(50，100μg)分別注射於阿控博核之次級區。結果發現安非他命直接注入阿控博核核區或古柯鹼注入阿控博核殼區可表現顯著的場地偏好效果。基於阿控博核所含有的麩胺酸神經末梢源自內側前額葉皮質，實驗三則發現安非他命或古柯鹼注入內側前額葉皮質可引發制約性場地偏好行為。實驗四將麩胺酸專屬受體抑制劑與安非他命共同注入核區或與古柯鹼共同注入殼區，結果發現不論NMDA或non-NMDA受體抑制劑均減抑了安非他命與古柯鹼注入阿控博核不同區所引發之制約性場地偏好的效果。最後實驗五利用內側前額葉遭破壞的受試，發現古柯鹼注入阿控博核殼區所引發之制約性場地偏好的效果受損，但不影響安非他命注入阿控博核核區所引發之制約性場地偏好的效果。綜觀上述結果顯示安非他命與古柯鹼的酬賞特質所引發行為的神經機制可能不同，腦中之內側前額葉皮質及阿控博核對兩藥的行為效果有不同的涉入。 / The function of the nucleus accumbens (NACC) has been suggestedto play an important role of the rewarding effects of psychostimulants.It is hypothesized that the neural substrates for amphetamine and cocaineto produce behavioral effects can be different. As conducted in Experiment 1, a conditioned place preference (CPP) task with procedures for amphetamine microinjection was established from the manipulation of conditioning environment. In considering the heterogeneity of NACC, Experiments 2 investigated the potentiality of the CPP effects after local infusion of amphetamine (10, 15 μg/site) or cocaine (50, 100 μg/site) into the core and shell subareas of NACC. Amphetamine microinjection into the NACC core significantly produced CPP, whereas such effect only appeared under treatment of the high dose of cocaine into the shell area. Lack of the CPP effects for amphetamine or cocaine infused into the boundary areas of the core and shell regions was seen in Experiment 2 (part B). In Experiment 3, the involvement of the medial prefrontal cortex (mPFC) was challenged for amphetamine and cocaine on the CPP task. Both doses of cocaine and the low dose of amphetamine locally infused in mPFC significantly produced CPP. In Experiment 4, glutamatergic NMDA receptor antagonist APV (0.5, 1 μg/site) and non-NMDA receptor antagonist CNQX (1 μg/site) significantly attenuated the CPP effects of amphetamine infused into the NACC core. This antagonism was also true for the cocaine-induced CPP in the NACC shell. These results implied that the other cortical areas can modulate such CPP effects, in particular the mPFC. In Eperiment 5, lesion of mPFC significantly inhibited the cocaine-induced CPP in the shell area but not for the amphetamine-induced CPP in the core area. Taken together, the NACC is an important neural substrate for mediating the rewarding effects for amphetamine and cocaine on the CPP task, and such effects can be dissociated as drugs locally infused into core and shell areas. Glutamatergic projections originating mPFC may provide some motivational information to the NACC. The mPFC may distinctly be involved in the motive circuit of cocaine- or amphetamine-induced CPP in the NACC. These results highlight that different processes are involved in the acquisition of CPP for microinjection of amphetamine or cocaine into the NACC subareas.

過去有關壓力的研究指出，當對實驗動物施予單次禁錮、足部或尾部電擊或是實驗者的抓取動作等壓力源時，其大腦中的前額葉皮質、杏仁核、依核或是紋狀體等處會有隨壓力源產生的多巴胺分泌量增加現象。相對於壓力源對腦中神經化學物質的探討，壓力源對與學習制約有關的行為影響的相關研究證據迄今如缺，因此本研究企圖建立單次壓力源操弄對場地制約偏好行為的動物模式。實驗一A對大白鼠施予單次30分鐘的高台壓力源，發現確實可建立場地制約偏好行為。實驗一B操弄單次高台壓力源觀察其對實驗動物自發性活動量的影響，結果發現其對於實驗受試在大動作持續時問上具有抑制效果。實驗一C操弄單次高台壓力源後的0、30、60及120分鐘時採取實驗受試的前額葉皮質、海馬體、杏仁核、依核及紋狀體等五處組織，檢驗其多巴胺、血清張力素及代謝物的含量。結果發現除海馬體外的四個部位的多巴胺量及其代謝物分別在不同採集時間點有不等的顯著增加現象。血清張力素的變化量在各個部位不及多巴胺。實驗二及實驗三分別經由周邊或中樞前額葉皮質微量注射多巴胺D₁與D₂專屬受體拮抗劑，結果發現其可抑制曲單次高台壓力源操弄所建立的場地制約偏好行為。綜合上述結果，單次高台壓力源的操弄確實可引發大白鼠大腦中的多巴胺量增加藉以形成場地制約偏好行為，而此場地制約偏好行為所依賴的多巴腰量增加位置推論其是依核而非前額葉皮質。另外，多巴胺D1與D2受體對此高台壓力源引發的場地制約偏好行為所扮演的角色相當。 / When experimental animals under single stressor, such as restraint, foot, or tail-shock, or handing, an immediate and robust releasing of dopamine appears in the prefrontal cortex, amygdala, nucleus accumbens, or striatum. In contrast to these neurochemical findings, the behavioral effects under stress are rarely studied and remained uncertain. The purpose of this study was to establish an animal model of single stress-induced conditioned place preference (CPP). Experiment 1A found that the CPP can be induced by a single high-plate stressor. Experiment 1B investigated the effects of this single high plate stressor on rats' locomotion, this stressor was found to inhibit the large movement as measured by duration. Experiment 1C investigated the timing course of this stressor on dopamine, serotonin, and their metabolities in the prefrontal cortex, hippocampus, amygdala, nucleus accumbens, and striatum. The results showed that all the areas, except hippocampus, had distinct patterns of changes on dopamine, serotonin and their metabolities at different times' after stress. Experiment 2 and 3, examined the effects ofdopamine D1 or D2 receptor antagonists, administered respectively via intraperitoneal or local infusion into the prefrontal cortex, on the CPP formed after high-plate stress. The results showed that these drug manipulations can inhibit stress-induced CPP. Taken together, these results indicated the CPP formed after high-plate stressor is developed on the immediate increase ofdopamine releases in the nucleus accumbens and prefrontal cortex. These neurochemical alterations are more profound in the nucleus accumbens than the prefrontal cortex. However, the dopamine D₁ and D₂ receptor in the prefrontal cortex are also important for the formation of CPP after high-plate stressor.

Reward-related learning occurs when previously neutral stimuli acquires an enhanced ability to elicit approach and other responses. Studies in the past have shown that dopamine receptor-mediated 3’,5’-cyclic adenosine monophosphate (cAMP)-dependent intracellular signalling is important for reward-related learning. Until recently, cAMP-dependent protein kinase (PKA) was the only known signalling molecule that was activated by cAMP. However, it has been discovered that another enzyme, exchange protein directly activated by cAMP (Epac), is also activated by cAMP. Thus, it is possible that cAMP mediates reward-related learning by an Epac-dependent signalling pathway. The present study used a conditioned place preference (CPP) paradigm to investigate whether Epac is involved in the acquisition of reward-related learning. Bilateral injections of amphetamine (20 µg/0.5μl/side) into the nucleus accumbens (NAc) have been shown in previous studies to reliably produce a CPP. Thus, amphetamine (20 µg) and Sp-adenosine 3’,5’-cyclic monophosphorothioate triethylamanine (Sp-cAMPS) (0.1, 1.0, 10, 15, 20 µg), an agent that activates both PKA and Epac, or amphetamine (20 µg) and 8-(4-chlorophenylthio)-2’-O-methyladenosine-3’,5’-cyclic monophosphate (8-pCPT) (0.73, 1.27, 1.45, 2.89, 5.78, 11.56 µg), an agent that selectively activates Epac, were co-injected into NAc to determine their effects on the acquisition of CPP. Results showed that 8-pCPT (1.45 µg), but not lower or higher doses, inhibited CPP. Sp-cAMPS (0.1, 15, 20 µg) also inhibited CPP, replicating the results of previous studies. The results implicate Epac in the acquisition of reward-related learning. / Thesis (Master, Neuroscience Studies) -- Queen's University, 2008-04-25 13:29:37.857

Thesis (Ph. D.) -- University of Texas Southwestern Medical Center at Dallas, 2004. / Vita. Bibliography: 127-149.

O núcleo acumbens (Acb) é subdividido em core e shell (AcbSh). Há evidências que as divisões do Acb vão além da dicotomia core-shell e que regiões pobres em tirosina hidroxilase (TH) e calretinina (Calr) formam um sistema de corredores no AcbSh. Para detalhar melhor a organização do Acb investigamos a distribuição de TH, Calr, DARPP-32 e do transportador de dopamina (DAT). Em seguida, foi comparada a distribuição destes marcadores com a das subunidades GluA2/3 dos receptores de glutamato do tipo AMPA. Finalmente, exploramos se as aferências pré-frontais são direcionadas à distintos compartimentos do AcbSh. Nossos resultados revelaram que regiões que contém neurônios GluA2/3+ intensamente marcados formam um sistema de corredores no AbSh que coincide com áreas pobres em TH, Calr e DAT. Os experimentos de rastreamento anterógrado indicaram que somente uma pequena parte das aferências pré-frontais é direcionada aos corredores. Nossos resultados delinearam um sistema de corredores no AcbSh que provavelmente constitui um compartimento neuroquímico altamente especializado. / The nucleus accumbens (Acb) is subdivided in core and shell (AcbSh). There is evidence that accumbal subdivisions go beyond this core-shell dichotomy and that regions poor in tyrosine hydroxylase (TH) and calretinin (Calr) form a corridor system in the Acbsh. To better detail accumbal organization, we investigated the distribution of TH, Calr, DARPP-32 and of the dopamine transporter (DAT). Then we compared the distribution of these markers with that of the AMPA-type glutamate receptor subunits GluA2/3. Finally, we explored whether prefrontal afferents are directed to distinct AcbSh compartments. Our findings revealed that regions containing intensely labeled GluA2/3+ neurons form a corridor system in the AcbSh that coincides with regions poor in TH, Calr, and DAT. Anterograde tracing experiments indicated that only a small portion of the prefrontal afferents is specifically related to the corridors. Our findings delineated a complex corridor system in the AcbSh which might constitute a highly specialized neurochemical compartment.